迈瑞医疗收盘下跌1.01%，滚动市盈率24.36倍，总市值2712.47亿元

Group 1 - The core viewpoint of the articles highlights that Mindray Medical's stock closed at 223.72 yuan, down 1.01%, with a rolling PE ratio of 24.36 times and a total market capitalization of 271.25 billion yuan [1] - The average PE ratio for the medical device industry is 49.51 times, with a median of 36.17 times, placing Mindray Medical at the 53rd position in the industry ranking [1] - As of March 31, 2025, Mindray Medical had 92,191 shareholders, an increase of 9,446 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Group 2 - Mindray Medical's main business includes the research, manufacturing, marketing, and service of medical devices, with key products in life information and support, in vitro diagnostics, medical imaging, electrophysiology, and vascular intervention [1] - The latest quarterly report for Q1 2025 shows that the company achieved operating revenue of 8.237 billion yuan, a year-on-year decrease of 12.12%, and a net profit of 2.629 billion yuan, down 16.81%, with a gross profit margin of 62.53% [1] - The PE ratios for Mindray Medical are 24.36 (TTM) and 23.25 (static), with a price-to-book ratio of 7.03 [2]